Powerful clot-blocking drug fails to beat standard pills in stubborn stroke subtype
A multicenter phase III trial found that intravenous tirofiban did not outperform standard oral antiplatelet therapy for 90-day functional outcomes ...
A multicenter phase III trial found that intravenous tirofiban did not outperform standard oral antiplatelet therapy for 90-day functional outcomes ...
A propensity score-matched analysis of the German Stroke Registry finds that rescue intracranial stenting after failed thrombectomy is associated with ...
A new meta-analysis in the Journal of Neurology finds that adding PCSK9 inhibitors to statin therapy more than doubled the ...
A new meta-analysis of six randomized trials shows that endovascular coiling yields better one-year functional outcomes overall, particularly for internal ...
Researchers in China have developed an exploratory AI framework that combines DWI lesion features, SWI-derived deep medullary vein markers, and ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.